Altrova Health Inc. (SSPLF)
Altrova Health Inc. is a venture capital firm specializing in incubation, seed/startups and early venture. It prefers to invest in drug, pharmaceuticals and tightly woven fabric, medtech and AI healthcare Spectrum, diagnostics, treatment, medical technology sectors. Altrova Health Inc. was founded in 2022 and is based in Vancouver, Canada.
Sector: Asset Management
Industry: Asset Management
Altrova Health Inc.
OTC:SSPLFFinancial Services · Asset Management
Mkt Cap-
EV-
Float119.41M
O/S169.03M
Inst Own-
Net Cash/Sh+$0.00
Dilution
MCap-Float119.41MO/S169.03M
Dilution
Financials Summary
Revenue$21K
Net Income-$3M
Total Assets$2.28M
Free Cash Flow-$672K
Debt & Equity
Equity 100%
Total Debt$0
Total Equity$1.68M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
- 1:4Reverse splitOct 3, 20234 shares → 1
Balance Sheet Details
Assets$2.28M
Liabilities$600K
Accounts Receivable$66K
Accounts Payable$376K
Inventory$0
PP&E (Net)$9K
Goodwill$2.03M
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Currency | USD | USD | USD |
| Period Ending | 2025-09-30 | 2024-09-30 | 2023-09-30 |
| Revenue | $21K | $200 | $0 |
| YoY Growth | 10247.7% | - | - |
| Cost of Revenue | $669K | $0 | $0 |
| Gross Profit | -$648K | $200 | $0 |
| Gross Margin | -3140.3% | 100.0% | - |
| Research and Development | $0 | $0 | $191K |
| Selling, General, and Administrative | $478K | $2.37M | $837K |
| Other | $166K | $1.14M | $3.4M |
| Total Operating Expenses | $478K | $3.52M | $4.42M |
| Operating Income (EBIT) | -$1.13M | -$3.52M | -$4.42M |
| Operating Margin | -5455.9% | -1762347.4% | - |
| Interest Expense | $0 | $0 | $0 |
| Interest Income | $0 | $200 | $7K |
| Other Income (Expense) | -$1.87M | -$487K | $9K |
| Income Before Tax (EBT) | -$3M | -$3.52M | -$4.41M |
| Income Tax Expense | $0 | $0 | $0 |
| Net Income | -$3M | -$3.52M | -$4.41M |
| Net Income Margin | -14523.6% | -1762347.4% | - |
| Supplementary Data | |||
| EPS | -0.03 | -0.07 | -0.30 |
| Diluted EPS | -0.03 | -0.07 | -0.30 |
| Weighted Average OS | 139.07M | 74.80M | 31.12M |
| EBITDA | -$3M | -$3.26M | -$2.88M |
| EBITDA Margin | -14513.1% | -1635370.5% | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Currency | USD | USD | USD |
| Period Ending | 2025-09-30 | 2024-09-30 | 2023-09-30 |
| Assets | |||
| Current Assets | |||
| Cash and Cash Equivalents | $130K | $279K | $2.64M |
| Short-Term Investments | $22K | $286K | $1K |
| Cash and Short-Term Investments | $152K | $565K | $2.64M |
| Accounts Receivable | $66K | $0 | $0 |
| Inventory | $0 | $0 | $0 |
| Other Current Assets | $2 | $0 | $100K |
| Total Current Assets | $234K | $615K | $2.95M |
| Long-Term Assets | |||
| Property, Plant & Equipment Net | $9K | $12K | $0 |
| Goodwill | $2.03M | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $0 |
| Total Long-Term Assets | $2.04M | $12K | $0 |
| Other Assets | $0 | $0 | $0 |
| Total Assets | $2.28M | $627K | $2.95M |
| Liabilities | |||
| Current Liabilities | |||
| Accounts Payable | $376K | $125K | $1.43M |
| Short-Term Debt | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 |
| Other Current Liabilities | $225K | $0 | $159K |
| Total Current Liabilities | $600K | $386K | $1.58M |
| Long-Term Liabilities | |||
| Long-Term Debt | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 |
| Total Long-Term Liabilities | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 |
| Total Liabilities | $600K | $386K | $1.58M |
| Stockholders' Equity | |||
| Preferred Stock | $0 | $0 | $0 |
| Common Stock | $11.11M | $6.98M | $5.67M |
| Retained Earnings | -$9.86M | -$7.93M | -$4.41M |
| Comprehensive Income & Other | $430K | $1.2M | $110K |
| Other Stockholders' Equity | $430K | $1.2M | $110K |
| Total Equity | $1.68M | $241K | $1.37M |
| Minority Interest | $0 | $0 | $0 |
| Total Liabilities and Equity | $2.28M | $627K | $2.95M |
| Supplementary Data | |||
| Total Debt | $0 | $0 | $0 |
| Net Debt | -$130K | -$279K | -$2.64M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Currency | USD | USD | USD |
| Period Ending | 2025-09-30 | 2024-09-30 | 2023-09-30 |
| Operating Activities | |||
| Net Income | -$3M | -$3.52M | -$4.41M |
| Depreciation & Amortization | $2K | $3K | $1.54M |
| Deferred Income Tax | $0 | $0 | $0 |
| Stock-Based Compensation | $0 | $1.18M | $0 |
| Changes in Working Capital: | |||
| Accounts Receivable | -$68K | -$149K | -$99K |
| Inventory | $0 | $0 | $0 |
| Accounts Payable | $0 | -$333K | $1.36M |
| Other Working Capital | $261K | $208K | -$72K |
| Total Working Capital Change | $193K | -$274K | $1.19M |
| Other Non-Cash Items | $2.13M | $483K | $1.03M |
| Net Cash from Operating | -$672K | -$2.13M | -$647K |
| Investing Activities | |||
| Capital Expenditures | $0 | -$14K | $0 |
| Acquisitions | $4K | $0 | $1.51M |
| Purchases of Investments | $0 | -$311K | $0 |
| Sales of Investments | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 |
| Net Cash from Investing | $4K | -$325K | $1.51M |
| Financing Activities | |||
| Debt Repaid | - | - | - |
| Common Stock Issuance | $519K | $91K | $2.16M |
| Common Stock Repurchases | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | -$389K |
| Net Cash from Financing | $519K | $91K | $1.77M |
| Forex Effect | -$8K | $0 | $0 |
| Net Change in Cash | -$157K | -$2.36M | $2.64M |
| Supplementary Data | |||
| Operating Cash Flow | -$672K | -$2.13M | -$647K |
| Capital Expenditure | $0 | -$14K | $0 |
| Free Cash Flow | -$672K | -$2.14M | -$647K |
| Cash at Beginning | $287K | $2.64M | $1.54M |
| Cash at End | $130K | $279K | $2.64M |